Tiziana Life Sciences (TLSA) has released an update.
Tiziana Life Sciences Ltd. has announced the voluntary resignation of its Chief Operating Officer and Chief Medical Officer, Matthew W Davis, MD, RPh, effective from August 2, 2024. The departure is due to personal reasons, with no reported disputes concerning company operations, policies, or practices. A search for Dr. Davis’ successor is underway, with further updates to come once a replacement is appointed.
For further insights into TLSA stock, check out TipRanks’ Stock Analysis page.
